Canada Markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
134.56-4.23 (-3.05%)
At close: 4:00PM EDT
133.50 -1.06 (-0.79%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close138.79
Open138.46
Bid133.00 x 1200
Ask133.65 x 1000
Day's Range130.64 - 138.60
52 Week Range76.59 - 331.68
Volume3,145,718
Avg. Volume5,413,210
Market Cap9.97B
Beta (5Y Monthly)1.62
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Newsfile

    Novavax Update

    Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 24, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novavax ("Novavax, Inc." or the "Company") (NASDAQ: NVAX).If you suffered losses exceeding $200,000 investing in Novavax stock or options and would like to discuss your

  • ACCESSWIRE

    INVESTOR ALERT - Labaton Sucharow is Investigating Novavax, Inc. (NASDAQ:NVAX) for Potential Securities Violations

    NEW YORK, NY / ACCESSWIRE / October 22, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential violations of the federal securities laws by Novavax, Inc.On October 19, 2021, after the market closed, Politico published an article titled, "'They Rushed the Process': Vaccine Maker's woes hamper global inoculation campaign," alleging manufacturing and purity problems in Novavax's process to produce Covid-19 vaccinations for COVAX, an in

  • Newsfile

    Novavax Shareholder Notice

    Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $200,000 In Novavax To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 22, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novavax ("Novavax, Inc." or the "Company") (NASDAQ: NVAX).If you suffered losses exceeding $200,000 investing in Novavax stock or options and would like to discuss your